Quinlan Paul T sold ORKA
September 15, 2026 · Form 4 insider transaction
Quinlan Paul T sold 1,039 shares of Oruka Therapeutics, Inc. at $95.71 per share, a transaction worth $99.4K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
1,039
Price
$95.71
Total value
$99.4K
InsiderQuinlan Paul T
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 15, 2026
Filing dateSeptember 15, 2026
Shares owned after29,995
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The reported sales were effected pursuant to Oruka Therapeutics, Inc.'s automatic, non-discretionary, sell-to-cover procedure to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units.